- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Vendor-Neutral Tool Streamlines AI Results Visualization and Delivery
Tools enable radiologist access to artificial intelligence.
CHICAGO - New tools are now available to help radiologists and clinicians access artificial intelligence (AI) results directly within their existing workflows.
At this year’s annual meeting of the Radiological Society of North America in Chicago, Fovia AI, Inc., a zero-footprint, cloud-based imaging SDK provider, released its XStream® aiCockpit™ and Xstream® aiPlatform™.
According to company data, XStream aiCockpit helps facilitate the connection between AI algorithms and PACS. It gives radiologists access to AI-driven workflows and visualizations that can be launched from any PACS, work list, dictation software, or hospital system. The software is 2D and 3D, and it’s accessible as a white-label product or through native integration. It also allows for efficient navigation and substantive interactions with AI results, real-time interactive tools, and local population validations.
As a vendor-neutral ecosystem, XStream aiPlatform connects AI developers, PACS, and hospital systems for effective delivery of AI-driven tools to radiologists. By selecting the algorithms that are made available, controlling the AI results flow, and letting those results be viewed with rich visualization capabilities, the product allows PACS to maintain control over the AI workflow.
XStream aiCockpit and XStream aiPlatform are compatible with several products already existing within the Fovia AI portfolio.
Mammography Study Suggests DBT-Based AI May Help Reduce Disparities with Breast Cancer Screening
December 13th 2024New research suggests that AI-powered assessment of digital breast tomosynthesis (DBT) for short-term breast cancer risk may help address racial disparities with detection and shortcomings of traditional mammography in women with dense breasts.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Can MRI-Based AI Bolster Biopsy Decision-Making in PI-RADS 3 Cases?
December 9th 2024In patients with PI-RADS 3 lesion assessments, the combination of AI and prostate-specific antigen density (PSAD) level achieved a 78 percent sensitivity and 93 percent negative predictive value for clinically significant prostate cancer (csPCa), according to research presented at the Radiological Society of North American (RSNA) conference.
